MRI assessment of response to treatment in NAC
Neoadjuvant chemotherapy (NAC) is offered to women with large, locally invasive breast tumours with an aim to downstage the tumour and enable breast conserving surgery. Traditionally it has been given to women with locally advanced disease, but increasingly now it is being offered to women with much smaller cancers and lower stage disease (IIb or […]
Dr E A M O'Flynn
Institute of Cancer Research and The Royal Marsden Hospital